A review of how far GLP-1 agonists have come – drugs for type 2 diabetes that help with not only blood sugar management, but with weight loss and heart health too
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
45 readers recommended
Recruiting 1,200 people with type 2 diabetes from diverse ethnic and racial backgrounds for a more thorough understanding of Soliqua’s impact on diabetes management
36 readers recommended
U500 insulin delivery through Omnipod pump, comparing insulin secretion between Mediterranean and ketogenic meals, a head-to-head with Afrezza and NovoLog, Qtern...
31 readers recommended
Trial shows that a pill version of Ozempic (semaglutide) can lower A1c by as much as 1.5% and also support weight loss
47 readers recommended
A new study is investigating whether higher doses of injectable GLP-1 agonist Trulicity (dulaglutide) are more effective; it is recruiting 1,800 participants with type 2...
69 readers recommended
Farxiga and Sotagliflozin are the first pills to seek approval as add-ons to insulin for type 1; both bring strong time-in-range benefits, and if approved, might launch...
41 readers recommended
The results were so positive it was deemed unethical to keep giving people placebo instead of Invokana, an SGLT-2 inhibitor approved for type 2 diabetes
44 readers recommended
New dose adjustment recommendations for adults and children using Dexcom's G5 CGM based on trend arrows and insulin sensitivity
33 readers recommended
Admelog is Sanofi’s version of Humalog (insulin lispro). New prescription savings card is for both Admelog and Lantus for people who would otherwise need to pay full...
30 readers recommended
The diaTribe Foundation and TCOYD hosted a panel discussion at the ADA 78 th Scientific Sessions in Orlando, Florida; read about insights on how to improve diabetes care
45 readers recommended
Phase 3 clinical trial currently recruiting 400 adults with type 2 diabetes
40 readers recommended
Two new studies will investigate whether SGLT-2 inhibitor Farxiga impacts heart failure in people with type 2 diabetes and prediabetes
34 readers recommended
Two new studies will investigate whether SGLT-2 inhibitor Jardiance impacts heart failure in people with and without diabetes. Jardiance is already approved to lower A1C...
60 readers recommended
Adults with type 1 and type 2 can now choose Fiasp, which can be taken up to 20 minutes after starting a meal and still be effective
24 readers recommended
ADA is around the corner, and there’s going to be exciting updates on diabetes drugs and therapy, devices, big picture questions, #beyondA1C, and advocacy; stay tuned!
55 readers recommended
People with type 2 can now get the once-weekly injectable in the US. The latest GLP-1 to show strong A1c-lowering and weight loss, Ozempic will also reach Europe in the...
33 readers recommended
Simple steps you can take to reduce your risk for heart failure. Plus, how to work with your health professional to manage it once you’ve been diagnosed.
43 readers recommended
Admelog will launch this year as the first approved biosimilar rapid-acting insulin. Will it be less expensive than Humalog?
34 readers recommended
Sanofi covers all insulins under this program, including Toujeo, Lantus, Admelog, Apidra.
26 readers recommended
A new study will investigate whether SGLT-2 inhibitor Farxiga can delay the progression of heart failure in people with and without type 2 diabetes